D68.5 – Primary thrombophilia
Coding Notes
Active
Non-billable / Non-specific, not valid for HIPAA-covered transactions
Type 1 Excludes
antiphospholipid syndrome (D68.61)
lupus anticoagulant (D68.62)
secondary activated protein C resistance (D68.69)
secondary antiphospholipid antibody syndrome (D68.69)
secondary lupus anticoagulant with hypercoagulable state (D68.69)
secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
thrombotic thrombocytopenic purpura (M31.19)
Applicable To
Primary hypercoagulable states
Child Codes
Sibling Codes
Parent Sibling Codes
View in Tabular
Code | Title |
---|---|
D50-D89 | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) |
D65-D69 | Coagulation defects, purpura and other hemorrhagic conditions (D65-D69) |
D68 | Other coagulation defects |
D68.5 |
Primary thrombophilia
Type 1 Excludes
antiphospholipid syndrome (D68.61)
lupus anticoagulant (D68.62)
secondary activated protein C resistance (D68.69)
secondary antiphospholipid antibody syndrome (D68.69)
secondary lupus anticoagulant with hypercoagulable state (D68.69)
secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
thrombotic thrombocytopenic purpura (M31.19)
Applicable to
Primary hypercoagulable states
|
D68.51 | Activated protein C resistance |
D68.52 | Prothrombin gene mutation |
D68.59 | Other primary thrombophilia |